Cumulative exposure to high remnant-cholesterol concentrations increases the risk of cardiovascular disease in patients with hypertension: a prospective cohort study

被引:21
作者
Wu, Weiqiang [1 ,2 ]
Chen, Guanzhi [3 ]
Wu, Kuangyi [1 ,2 ]
Zheng, Huancong [1 ,2 ]
Chen, Yanjuan [4 ]
Wang, Xianxuan [2 ]
Huang, Zegui [2 ]
Cai, Zefeng [1 ]
Cai, Zhiwei [1 ,2 ]
Chen, Zhichao [1 ]
Lan, Yulong [1 ]
Chen, Shuohua [5 ]
Wu, Shouling [5 ]
Chen, Youren [1 ]
机构
[1] Shantou Univ Med Coll, Affiliated Hosp 2, Dept Cardiol, 69 Dongxia North RD, Shantou 515000, Peoples R China
[2] Shantou Univ, Med Coll, Shantou, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Cardiac Arrhythmia Ctr, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
[4] Shantou Univ Med Coll, Affiliated Hosp 2, Dept Endocrinol, Shantou, Peoples R China
[5] Kailuan Gen Hosp, Dept Cardiol, 57 Xinhua East RD, Tangshan 063000, Peoples R China
关键词
Remnant cholesterol; Cumulative exposure; Hypertension; Cardiovascular disease; BLOOD-PRESSURE; VARIABILITY; INFARCTION; MORTALITY; GLUCOSE; STROKE;
D O I
10.1186/s12933-023-01984-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The relationship of cumulative remnant-cholesterol (Cum-RC) concentration with the risk of cardiovascular disease (CVD) in patients with hypertension remains unclear.Methods We studied data for 28,698 individuals for whom three consecutive total cholesterol, high-density lipoprotein-cholesterol (HDL-C), and triglyceride concentrations were available, and who did not have CVD (14,349 with hypertension and 14,349 without), that was collected between 2006 and 2010. Participants with hypertension were placed into four groups based on Cum-RC quartile: a Q1 group (< 26.40 mg/dl), a Q2 group (26.40-39.56 mg/dl), a Q3 group (39.57-54.65 mg/dl), and a Q4 group (= 54.66 mg/dl). Cox proportional hazards models were used to evaluate the relationship between Cum-RC and the risk of CVD.Results Over a median 10.9 (interquartile range, 10.5-11.3) years, 1,444 participants with hypertension developed CVD. After adjustment for multiple potential confounding factors, and compared with the Q1 Cum-RC group of the participants with hypertension, the adjusted hazard ratios for CVD for the Q2-Q4 groups were 1.07(0.92,1.26), 1.08(0.91,1.28), and 1.26(1.03,1.54) (P = 0.0405); those for myocardial infarction were 1.51(1.00,2.31), 2.02(1.22,3.27), and 2.08(1.41,3.28) (P < 0.0001); and those for ischemic stroke were 1.02(0.84,1.24), 1.04(0.86,1.25), and 1.29(1.02,1.62), respectively (P = 0.0336). However, no significant relationship was found between Cum-RC and the risk of hemorrhage stroke. At the same Cum-RC, the risk of CVD was significantly higher in participants with hypertension than in those without.Conclusions A consistently high remnant-cholesterol concentration increases the risk of CVD in individuals with hypertension. Therefore, the achievement of blood pressure and RC concentration targets should help reduce the risk of CVD in individuals with hypertension.
引用
收藏
页数:11
相关论文
共 46 条
[1]  
Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI [10.1161/CIR.0000000000000659, 10.1161/CIR.0000000000000746]
[2]   Remnant Cholesterol The Leftovers and Their Contribution to Atherosclerotic Cardiovascular Disease [J].
Bruemmer, Dennis ;
Cho, Leslie .
CIRCULATION-CARDIOVASCULAR IMAGING, 2021, 14 (04) :336-339
[3]   Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk [J].
Burnett, John R. ;
Hooper, Amanda J. ;
Hegele, Robert A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (23) :2736-2739
[4]   Central role of c-Src in NOX5-mediated redox signalling in vascular smooth muscle cells in human hypertension [J].
Camargo, Livia L. ;
Montezano, Augusto C. ;
Hussain, Misbah ;
Wang, Yu ;
Zou, Zhiguo ;
Rios, Francisco J. ;
Neves, Karla B. ;
Alves-Lopes, Rheure ;
Awan, Fazli R. ;
Guzik, Tomasz J. ;
Jensen, Thomas ;
Hartley, Richard C. ;
Touyz, Rhian M. .
CARDIOVASCULAR RESEARCH, 2022, 118 (05) :1359-1373
[5]   The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes [J].
Cao, Ye-Xuan ;
Zhang, Hui-Wen ;
Jin, Jing-Lu ;
Liu, Hui-Hui ;
Zhang, Yan ;
Gao, Ying ;
Guo, Yuan-Lin ;
Wu, Na-Qiong ;
Hua, Qi ;
Li, Yan-Fang ;
Li, Xiao-Lin ;
Xu, Rui-Xia ;
Cui, Chuan-Jue ;
Liu, Geng ;
Dong, Qian ;
Sun, Jing ;
Zhu, Cheng-Gang ;
Li, Jian-Jun .
CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
[6]   Association of remnant cholesterol and non-high density lipoprotein cholesterol with risk of cardiovascular mortality among US general population [J].
Cheang, Iokfai ;
Zhu, Xu ;
Shi, Shi ;
Tang, Yuan ;
Yue, Xin ;
Liao, Shengen ;
Yao, Wenming ;
Zhou, Yanli ;
Zhang, Haifeng ;
Li, Yanxiu ;
Li, Xinli .
HELIYON, 2022, 8 (08)
[7]   High Remnant Cholesterol Level Potentiates the Development of Hypertension [J].
Chen, Ming-Ming ;
Huang, Xuewei ;
Xu, Chengsheng ;
Song, Xiao-Hui ;
Liu, Ye-Mao ;
Yao, Dongai ;
Lu, Huiming ;
Wang, Gang ;
Zhang, Gui-Lan ;
Chen, Ze ;
Sun, Tao ;
Yang, Chengzhang ;
Lei, Fang ;
Qin, Juan-Juan ;
Ji, Yan-Xiao ;
Zhang, Peng ;
Zhang, Xiao-Jing ;
Zhu, Lihua ;
Cai, Jingjing ;
Wan, Feng ;
She, Zhi-Gang ;
Li, Hongliang .
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[8]   Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy? [J].
Dallinga-Thie, Geesje M. ;
Kroon, Jeffrey ;
Boren, Jan ;
Chapman, M. John .
CURRENT CARDIOLOGY REPORTS, 2016, 18 (07)
[9]   Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients. Beyond LDL cholesterol and hypolipidemic treatment [J].
Delialis, Dimitrios ;
Georgiopoulos, Georgios ;
Aivaliot, Evmorfia ;
Mavraganis, Georgios ;
Dimopoulou, Angeliki-Maria ;
Sianis, Alexandros ;
Aggelidakis, Lasthenis ;
Patras, Raphael ;
Petropoulos, Ioannis ;
Ioannou, Sofia ;
Syrigou, Rodanthi ;
Chazidou, Sofia ;
Kanakakis, Ioannis ;
Stellos, Konstantinos ;
Stamatelopoulos, Kimon .
HELLENIC JOURNAL OF CARDIOLOGY, 2022, 66 :26-31
[10]   Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort [J].
Fu, Liyao ;
Tai, Shi ;
Sun, Jiaxing ;
Zhang, Ningjie ;
Zhou, Ying ;
Xing, Zhenhua ;
Wang, Yongjun ;
Zhou, Shenghua .
DIABETES CARE, 2022, 45 (09) :2136-2143